Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Early relapses, onset of progression, and late outcome in multiple sclerosis.
ATX-MS-1467, An Immunotolerizing Agent, Halts Disease Progression and Reduces CNS Inflammation in Rodent Models of Multiple Sclerosis (P1.216)
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling.
Embryonic stem cell lines derived from human blastocysts.
Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
Teva to present positive data for glatiramer acetate 40 mg/1 ml given three times weekly for relapsing-remitting MS
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Fingolimod modulates microglial activation to augment markers of remyelination.
Daclizumab (anti-CD25) in multiple sclerosis.
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.

Pages